Topline Capital Management LLC acquired a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 179,540 shares of the company's stock, valued at approximately $5,690,000. Nutex Health comprises about 1.1% of Topline Capital Management LLC's holdings, making the stock its 18th largest holding. Topline Capital Management LLC owned 3.30% of Nutex Health at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of NUTX. Beaird Harris Wealth Management LLC acquired a new position in Nutex Health during the 3rd quarter valued at about $69,000. Geode Capital Management LLC boosted its position in Nutex Health by 12.6% during the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock worth $1,082,000 after acquiring an additional 3,826 shares during the period. Truist Financial Corp grew its stake in shares of Nutex Health by 22.2% in the fourth quarter. Truist Financial Corp now owns 35,570 shares of the company's stock worth $1,127,000 after purchasing an additional 6,454 shares in the last quarter. Baader Bank Aktiengesellschaft bought a new stake in shares of Nutex Health during the fourth quarter valued at about $206,000. Finally, Legato Capital Management LLC lifted its holdings in Nutex Health by 26.8% in the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock worth $1,004,000 after purchasing an additional 6,697 shares during the period. Institutional investors own 5.32% of the company's stock.
Insiders Place Their Bets
In related news, CFO Jon Christian Bates bought 1,000 shares of the business's stock in a transaction dated Tuesday, April 8th. The shares were bought at an average cost of $81.81 per share, with a total value of $81,810.00. Following the completion of the transaction, the chief financial officer now directly owns 4,888 shares of the company's stock, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 38.52% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Separately, Maxim Group increased their price objective on shares of Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a report on Tuesday, April 8th.
Read Our Latest Stock Report on NUTX
Nutex Health Price Performance
Shares of Nutex Health stock traded up $3.48 during trading on Wednesday, hitting $108.29. The stock had a trading volume of 108,796 shares, compared to its average volume of 58,558. The business has a fifty day moving average of $80.52 and a two-hundred day moving average of $51.54. The firm has a market cap of $598.63 million, a P/E ratio of -11.54 and a beta of 0.27. Nutex Health Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $152.51. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74.
Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $81.30 million during the quarter, compared to analyst estimates of $81.13 million.
Nutex Health Profile
(
Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
